UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 19,
Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Aquestive Therapeutics Charts.
Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics, Inc. News

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
Monday 29 April 2024 (3 days ago) • GlobeNewswire Inc.
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.
Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
Saturday 13 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.
Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

More Aquestive Therapeutics, Inc. News Articles